To test whether the product of the bcl-2 proto-oncogene blocks clonal deletion of self-reactive B cells, we have generated transgenic mice carrying the bcl-2 gene and the immunoglobulin genes for the anti-erthrocyte 4C8 antibody. In these transgenic mice, donal deletion of self-reactive immature B cells in the bone marrow was not inhibited in spite of expression of the bcl-2 gene. In contrast, self-antigen-induced donal deletion of mature self-reactive Ly-1 B (B1) cells in the peritoneal cavity was inhibited in the transgenic mice. These results indicate that the mechanism for clonal deletion of immature self-reactive B cells in the bone marrow differs from that of mature self-reactive B cells in the periphery.
I
g V gene diversity is amplified by somatic DNA rearrange-. ment in B cell precursors of the bone marrow and fetal liver, and by somatic mutations in mature B cells of the peripheral lymphoid organs. Such amplification of diversity allows the immune system to react with almost all possible foreign antigens. The Ig repertoire amplified by genetic mechanisms, includes Ig reactive to self as well as foreign antigens and thus, without appropriate selection, self-reactive B cells inevitably emerge.
Studies on autoantibody transgenic mice (1) (2) (3) (4) (5) have clearly demonstrated that self-reactive B cells are surveyed by multiple mechanisms of immunological tolerance (6) (7) (8) . Soluble self-antigens render self-reactive B cells to an inactive state, in which B cells fail to respond to the stimulation by antigens and T helper cells (clonal anergy). Membrane-bound self-antigens eliminate self-reactive B cells presumably by strong cross-linking of surface Ig (slg) 1 receptors (donal deletion). In transgenic mice which produce autoantibodies reactive to self-antigens expressed in the bone marrow, both bone marrow and peripheral B cells are tolerized by either anergy or deletion, suggesting that the bone marrow immature B cells may be the major target of the B cell tolerance (1, 3, 5) . However, the transfer experiment of mature self-reactive B cells into mice producing self-antigens revealed that mature B cells can be also anergized (1) . Since self-antigens in the liver elimi-1 Abbreviations used in this paper: Ht, hematocrit; MFI, mean fluorescence intensities; NP, 4-(hydroxy-3-nitrophenyl)acetyl; slg, surface Ig. nated self-reactive B cells in the periphery but not in the bone marrow (9) , clonal deletion also appears to take place at some stage after B cells migrate from the bone marrow to the periphery.
We have analyzed a transgenic mouse line expressing both H and L chains of the 4C8 antierythrocyte autoantibody in almost all the B cells (5) . As is the case for other autoantibody transgenic mice (1, 3) , the number of B cells in the bone marrow, spleen, and lymph nodes in these transgenic mice are markedly reduced most likely because of clonal deletion at the immature B cell stage in the bone marrow by interaction with RBCs and/or their precursors. However, mature Ly-1 B cells reacting to RBCs are found in the peritoneal cavity presumably because the peritoneal cavity is sequestered from self-antigens (RBCs). These mature Ly-1 B cells undergo apoptotic cell death upon intraperitoneal injection of RBCs (10) . Thus, both immature bone marrow B cells and mature Ly-1 B cells are eliminated by interaction with the self-antigens in these mice.
Accumulating evidence suggests that bone marrow immature B cells and peripheral mature B cells are functionally distinct. Immature B cells do not respond to cross-linking of the slg in vitro, whereas the same stimulation induces DNA synthesis in mature B cells (11) . Further evidence comes from the observation that slg-associated molecules and signal transduction pathways via slg receptor complexes are different in immature and mature B cells (12) . In spite of these differences, no data refer to distinct tolerance mechanisms between B cells in the bone marrow and the periphery.
The bcl-2 proto-oncogene was found as a result of its trans-location to the Ig H chain locus in most human follicular center B cell lymphomas (13) . The bcl-2 gene product has been shown to delay the onset of apoptotic cell death in certain hematopoietic cell lines deprived of growth factors (14) (15) (16) (17) .
Besides the inhibition of apoptosis in these cell lines, the bd-2 gene product also inhibits apoptosis of normal lymphocytes. Indeed, Strasser et al. (18) and Sentman et al. (19) found that anti-CD3 antibody-induced apoptosis of immature thymocytes was inhibited in bcl-2 transgenic mice. These transgenic mice, however, showed little, if any, abrogation of clonal deletion of T cells reactive to self-superantigens, suggesting that self-tolerance is maintained by multiple mechanisms, some of which are not perturbed by bcl-2.
To assess whether bcl-2 inhibits elimination of self-reactive B cells in both the periphery and the bone marrow, we analyzed antigen-induced elimination of peripheral Ly-1 B cells and clonal deletion of immature B cells in the bone marrow in transgenic mice carrying the genes for bcl-2 and the antierythrocyte antibody. The data shown here demonstrate that the bcl-2 gene product inhibits clonal deletion of peritoneal Ly-1 B cells but not that of bone marrow immature B cells, suggesting that distinct mechanisms are involved in selftolerance of B lymphocytes in central and peripheral lymphatic organs.
Materials and Methods
Transgenic Mice. The transgenic mouse lines carrying either Ig /~ or L chain gene for antierythrocyte antibody (4C8 mAb) were established as described by Okamoto et al. (5) and maintained in our animal colony. The El~-bcl-2 transgenic line was kindly donated by Dr. A. Strasser (18) . The transgenic line carrying # chain gene for anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibody was kindly donated by Drs. T. Era and S.-I. Nishikawa (20) .
Flow Cytometry and CelISorting. Cells from the spleen, the bone marrow, and the peritoneal cavity of mice were applied to FicollHypaque gradient centrifugation, and mononuclear calls enriched at the interface layer were used for flow cytometric analysis. Single cell suspensions were stained with appropriate antibodies, and analyzed by FACScan | (Becton Dickinson & Co., Mountain View, CA) after exclusion of dead cells by propidium iodide gating. Twocolor staining of the cells with anti-B220 and anti-IgM antibodies was done as described by Okamoto et al. (5) . The amounts of autoantibodies on erythrocytes were measured with flow cytometry using FITC goat anti-mouse IgM antibody (Cappd Laboratories, Malvern, PA) (5). Mean fluorescence intensities (MHs) were obtained with the equation: MFI = 10 Ix/zs2) (X = mean fluorescence). Bone marrow cells from El~-bcl-2 transgenic mice were stained with anti-B220 (6B2) and anti-slgM antibodies. B220 + sIgM-and B220" sIgM + cells were sorted using FACStar | and the consort 30 program (Be, ton Dickinson & Co.).
Polymerase Chain Reaction. %tal cytoplasmic RNA was extracted from 10 s splenocytes or bone marrow cells of mice using the RNase inhibitor vanadyl ribonucleotide complex (21) . Random primed first strand cDNA synthesis was carried out using abelson murine leukemia virus (AMV) reverse transcriptase (Seikagaku Kogyo, Tokyo, Japan). The cDNA was amplified with human bcl-2 primers; 5' primer, ACACGCCCCATACAGCCGCAT and 3' primer, CAAGCTCCCACCAGC~CCAAA for 30 cycles on a DNA thermal cycler (Perkin Elmer Corp., Nowalk, CT). The expected size of the amplified band is 522 bp.
ELISA. The numbers of antibody-producing cells in 105 cells of the spleen, the bone marrow, the lymph nodes, and the peritoneal cavity from mice at 8 wk of age were analyzed with enzymelinked immunospot assay using anti-idiotype antibody ($54) as described by Murakami et al. (10) .
Induction and Assay of Peritoneal Cell Death. 8-wk-old mice were injected intraperitoneously with 109 RBCs in 500 #1 of PBS. 12 h after injection, peritoneal ceils from each mouse were subjected to flow cytometry and DNA fragmentation assay. DNA was isolated from peritoneal cells as described by Ishida et al. (22) . The sample was electrophoresed in a 2% agarose gel with TAE buffer (40 mM Tris-acetate, 1 mM ~, pH 8.0). DNA was subsequently visualized by ethidium bromide staining.
Results
Autoimmune Symptoms in Transgenic Mice Carrying bcl-2 and Anti-erythrocyte Autoantibody Genes. To examine the effect of the bcl-2 gene on B cell tolerance, we analyzed transgenic mice expressing both the 4C8 antierythrocyte autoantibody and the bcl-2 gene in B lineage cells (bcl-2 x H x L mice).
We assessed the incidence of anemia and the amounts of autoantibodies produced by measuring hematocrit (Ht) and quantitating autoantibodies bound to circulating erythrocytes ofS-wk-old bcl-2 x H x L mice. As a control, we examined transgenic mice carrying only the H and L chain genes for the antierythrocyte antibody (H x L mice) at the same age under the same breeding conditions. Both bcl-2 x H x L and H x L mice showed wide variations of the Ht values and the amounts of autoantibodies on RBCs (Fig. 1, a and b). The Ht value in each transgenic mouse was inversely proportional to the amount of the autoantibody bound to erythrocytes, indicating that the autoantibodies are responsible for hemolytic anemia as previously shown for H x L mice (5). About one third of bcl-2 x H x L mice showed Ht values <35%, whereas all of the H x L mice showed Ht values >35%, indicating the enhanced occurrence of the autoimmune disease by introduction of the bet-2 transgene. This finding is also supported by the increased amounts of the autoantibody bound to erythrocytes in bcl-2 x H x L mice as compared with H x L mice. Nevertheless, two thirds ofH x L mice and one third ofbcl-2 x H x L mice showed neither anemia (Ht <40%) nor autoantibody production (MFI >50), indicating that self-reactive B cells are toterized at least in some individuals of bcl-2 x H x L mice as well asH x Lmice.
To identify B cells responsible for the autoimmune disease manifested in two thirds of bcl-2 x H x L mice, we compared the number of B cells in various lymphoid organs in severely anemic (Ht <35%) and nonanemic (Ht >40%) bcl-2 x H x L mice. The numbers of B cells in the bone marrow and spleen of bcl-2 x H x L mice were decreased to the same level regardless of their Ht values as shown in H x L mice (10) . We next examined the number of autoantibody-producing cells in the spleen, bone marrow, lymph nodes, and peritoneal cavity in bd-2 x H x L mice. The number of antibody-producing cells in the peritoneal cavity of anemic bcl-2 x H x L mice was markedly increased To show that maintenance of clonal deletion of self-reactive B cells in the bone marrow in bcl-2 x H x L mice is not due to lack of bcl-2 expression in immature B cells, we sorted pre-B cells (B220 + slgM-) and B cells (B220 + sIgM hi) from the bone marrow of bcl-2 mice (Fig. 3 a) and examined bcI-2 expression in these populations by reverse PCR. Splenocytes of bcl-2 mice were used as a positive control. The bcl-2 gene was amplified from cDNA of both pre-B and B cells in bcl-2 mice (Fig. 3 b) . In contrast, the bcl-2 gene was not amplified in the absence of reverse transcriptase, indicating that genomic DNA was not contaminated in the cDNA samples. Taken together, the bcl-2 gene product does not inhibit clonal deletion of self-reactive immature B cells in the bone marrow.
In bcb2 x H x L mice, a normal number ofLy-1 B cells (B220 ~~ sIgMhi), but only few conventional B cells (B220 hi slgM 1~ were observed in the peritoneal cavities (Fig. 2 c) Although both immature and mature self-reactive B cells have been shown to be clonally deleted by signaling via slg receptors upon interaction with self-antigens (10, 11), mechanisms for antigen-induced elimination of self-reactive B cells appear to be different in immature and mature B cells. This could be due to the fact that signaling pathways via slg receptors are different between the two stages of B cells (11, 12) . Different responses to self-antigen stimulation by immature and mature B cells were also shown by recent studies on autoantibody transgenic mice (27, 28) demonstrating that cross-linking of slg induced replacement of the Ig r chain in self-reactive immature B cells, not in mature B cells. Moreover, maturation arrest but not antigen-induced apoptosis might be involved in clonal deletion of immature B cells (25) . Mature B cells are able to respond to foreign antigens, suggesting that stimulation with foreign antigens may activate the machinery rescuing slg-mediated apoptosis of mature B cells. We have shown that signaling through slg does not kill but activates normal B cells in the peritoneal cavity in bd-2 transgenic mice (Tsubata et al., manuscript submitted for publication). Presumably bd-2 may play a role in the rescue machinery of mature B cells from slg-mediated apoptosis.
Hemolytic anemia was more frequent and severe in bcl-2 x H x L mice than in H x L mice. Moreover, the severity of hemolytic anemia is proportional to the number of autoantibody producing cells in the peritoneal cavity, in agreement with the finding with H x L mice (10) 
